Recently, the breast milk oligosaccharide (hereinafter referred to as HMOs ) 2 ′ -fucosyl lactose (hereinafter referred to as 2 ′ -FL ) under Quantum Hi-Tech has officially been approved by the National Health Commission ( Announcement No. 6 of 2024 ) as a food nutrition enhancer, which can be used for the development of infant formula foods, larger babies, young children formula foods, special medical uses infant formula foods and milk powders (children milk powder only). This is the first approved product in the Quantum Hi-Tech HMOs series, marking a new journey towards the precise prebiotic development strategy that the company has deeply implemented. Next, Quantum Hi-Tech will use the advantageous resources of Tate & Lyle Group to accelerate the development and commercial layout of HMOs series products, thereby providing Chinese babies with richer early-life nutrition solutions and promoting the high-quality development of China's infant and toddler market.

Committed to the study of localized HMOs population

As the leader of the prebiotic industry, Quantum Hi-Tech is an early domestic company that entered the HMOs field and focuses on localized population research. Through the changes in the HMOs composition of Chinese mothers' breast milk, the population differences in fucosylated HMOs , and the relationship between HMOs and Lewis blood type, more biological codes and regulatory information about the protection and nutrition of maternal larvae carried in HMOs are revealed . Many research results of this project have been published in domestic and foreign journals.

Pay more attention to the utilization of HMOs by infants and young children

Adhering to the development requirements of the prebiotic precision strategy, the correspondence between the "structure - fungus - function" of individual ingredient prebiotics has always been the focus of Quantum Hi-Tech for breakthroughs and improvements. Unlike focusing only on the differences in composition and content of secreted and non-secreted HMOs , Quantum Hi-Tech focused more on the research on the utilization of HMOs in infants and young children, evaluating the impact of HMOs on infant intestinal microecology development based on indicators such as bacterial flora and metabolite yield . It was found that the diversity of infant intestinal flora of different HMOs metabolic types is significantly different, and the different HMOs metabolism types in infants are closely related to the corresponding flora composition.

More abundant early life nutrition solutions

Among more than 1,000 HMOs with different structures , only about 200 structures can be identified. How to better simulate and apply the relatively complex combination of breast milk oligosaccharides in infant formula foods is the most important challenge? With years of research on prebiotics in bacterial flora, metabolism, immunity and nutrition, Quantum Hi-Tech has carried out synergy between one or more HMOs , including 2' - FL and other precise prebiotics, focusing on functional research in multiple directions such as immunity, intestinal health and potential cognitive development, providing solutions for accurately developing formula foods that are closer to the ingredients and functions of Chinese mothers' breast milk and more suitable for the needs of Chinese babies.